Announcement of Establishment of a Subsidiary in the Commonwealth of Australia

Remedy & Company Corporation is pleased to announce that we have established a wholly owned subsidiary in Australia, REMEDY & COMPANY OCEANIA PTY LTD.

【Background and Objective】

In recent years, Australia has attracted attention from around the world as a country where clinical trials are conducted due to its advanced level of environment for drug development.

In addition to the quality of research, facilities, and researchers, there is an administrative support at the national level, such as tax incentives for drug development, and compared to other countries, the startup timeline for clinical trials can be short compared to other developed markets.
By establishing a local subsidiary in Australia, we will provide customers with new options for clinical trials and will contribute to further promoting clinical trials originating in Japan and strengthening Japan's drug discovery capabilities.

【REMEDY & COMPANY OCEANIA PTY LTD.】

About Remedy & Company:
Remedy & Company Corporation (formerly known as intellim Holdings Corporation) was established in 2018.
Its predecessor, intellim Corporation, which was founded in 2005 with main aim of developing CRO business.
Subsequently, intellim Holdings Corporation (now known as Remedy & Company Corporation) was established in 2018 as the core driving intellim Corporation and other group companies in Japan and abroad to create innovative solutions in drug development within Japan and abroad.
In April 2022, the company changed its name to Remedy & Company Corporation and made a new start with the goal of becoming a global health tech platform that transcends the boundaries of a CRO.
Remedy & Company Corporation oversees group companies including intellim Corporation, iRIS Corporation, Quantum Healthcare Corporation and Remedy XR Corporation, and its business objective is to achieve further growth for the world, healthcare, and customers, while utilizing the latest technology and innovation.
Head office moved to the TOKYO TORCH Tokiwabashi Tower in January 2023.
Remedy group currently has offices in 9 countries. (as of November 2023)
For more information, please visit our website：https://www.remedy-company.com/en/